11/15
Penn's Basser Research Center for BRCA Brings Mission Into U.S. Synagogues
This fall, the University of Pennsylvania’s Basser Research Center for BRCA is taking its lifesaving efforts to raise awareness about hereditary breast and ovarian cancers on the road and into synagogues across the country.
Penn Medicine Study: Cancer Drug Shortages Hit 83 Percent of U.S. Oncologists
Eighty-three percent of cancer doctors report that they’ve faced oncology drug shortages, and of those, nearly all say that their patients’ treatment has been impacted, according to a study from researchers at the Abramson Cancer Center and the Perelman School of Medicine at the University of P
Penn Medicine Study: Targeted Therapy Sorafenib Shows Success in Advanced Differentiated Thyroid Cancer Patients
The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to results of a randomized phase III trial, which will be presented today by a researcher from the Abramson Cancer Center and the Perelman School of Medicine at the
Penn Medicine Reveals New Potential Therapy for Advanced Cancers
In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers.
Penn Study Shows One Quarter of Patients Discharged from Hospitals Return for Emergency Care Within 30 Days
A study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and Boston University School of Medicine has found that nearly one quarter of patients may return to the emergency department within 30 days of being discharged from a hospitalization.
Penn Medicine: Lack of Consensus Among Health Care Providers in Identifying Sepsis Poses Threat
Though the toll of sepsis is known to be enormous – it is estimated to cost the U.S. health care system $24.3 billion each year, and is the nation’s third-leading killer, behind heart disease and cancer – the true magnitude of incidence of and death from the illness remains unknown.
Penn Medicine Team Draws Map to Avoid Detours on Road to HIV Treatment Success
Addressing on the challenges that accompany transitions between health care settings could be a key strategy for improving clinical outcomes for people living with HIV, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.
Penn Physician: Emphasis on 'Value' in Reform Sends Mixed Messages
The wide consensus that health care spending poses a threat to the nation’s fiscal solvency has led to the championing of “value” as a goal of health care reform efforts.
Two-Step Immunotherapy Attacks Advanced Ovarian Cancer, Penn Medicine Researchers Report
PHILADELPHIA — Most ovarian cancer patients are diagnosed with late stage disease that is unresponsive to existing therapies.
Penn Study of Breast Cancer Message Boards Finds Frequent Discussion of Drug Side Effects
PHILADELPHIA — In the first study to examine discussion of drug side effects on Internet message boards, researchers from the Perelman School of Medicine at the University of Pennsylvania found that breast cancer survivors taking the commonly prescribed adjuvant therapy known as aromatase inhibitors (AIs) often detailed in these forums troublesome symptoms resulting from the drugs, and they we